Connection

Erik Swenson to Acetazolamide

Back to Details
This is a "connection" page, showing publications Erik Swenson has written about Acetazolamide.
Erik Swenson
Connection Strength
1.435
Acetazolamide
  1. Acetazolamide Use in Severe Chronic Obstructive Pulmonary Disease. Pros and Cons. Ann Am Thorac Soc. 2017 Jul; 14(7):1086-1093.
    View in: PubMed
    Score: 0.692
  2. COVID-19 Lung Injury and High-Altitude Pulmonary Edema. A False Equation with Dangerous Implications. Ann Am Thorac Soc. 2020 08; 17(8):918-921.
    View in: PubMed
    Score: 0.214
  3. Effect of acetazolamide and methazolamide on diaphragm and dorsiflexor fatigue: a randomized controlled trial. J Appl Physiol (1985). 2018 09 01; 125(3):770-779.
    View in: PubMed
    Score: 0.184
  4. Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge's disease). Respir Physiol Neurobiol. 2017 12; 246:1-8.
    View in: PubMed
    Score: 0.173
  5. Findings of Cognitive Impairment at High Altitude: Relationships to Acetazolamide Use and Acute Mountain Sickness. High Alt Med Biol. 2017 Jun; 18(2):121-127.
    View in: PubMed
    Score: 0.171
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.